Article info

Download PDFPDF
Extended report
Effect of rituximab on malignancy risk in patients with ANCA-associated vasculitis

Authors

  1. Correspondence to Emma Elisabeth van Daalen, Department of Pathology, L1-Q (P0-107), Leiden University Medical Centre, P.O. Box 9600, Leiden 2300 RC, The Netherlands; E.E.van_Daalen{at}lumc.nl
View Full Text

Citation

van Daalen EE, Rizzo R, Kronbichler A, et al
Effect of rituximab on malignancy risk in patients with ANCA-associated vasculitis

Publication history

  • Received May 20, 2016
  • Revised November 10, 2016
  • Accepted November 12, 2016
  • First published November 29, 2016.
Online issue publication 
May 13, 2017

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.